Stock & Company Details
Connect Biopharma Holdings Limited $CNTB
Price:
N/A
N/A
63M
$144M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.93
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
CNTB technical indicators
Latest Connect Biopharma Holdings Limited (CNTB) indicator readings as of 2026-08-28.
CNTB's 14-day RSI is 46.7, in neutral territory. At $2.23 it is trading 9.6% below its 200-day moving average of $2.47, and below its 50-day average of $2.26. Price sits in the middle of its Bollinger Bands ($2.00 to $2.60). ADX reads 15.7, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Finance Bot
Ask your questions
Start by typing a question below.
